等待開盤 10-25 09:30:00 美东时间
+0.009
+2.01%
Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high populationIncreasing DKK1 levels further improved PFS, OS, and ORR advantage for the Sirexatamab ArmLeap to continue supporting
10-20 19:07
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- USA News Group News Commentary – Major pharmaceutical companies are unveilin...
10-07 21:00
Leap Therapeutics ( ($LPTX) ) has shared an announcement. On October 6, 2025, L...
10-06 21:28
Leap Therapeutics (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced $58,888,888 in cash commitments for a private investment in public equity ("PIPE")
10-06 21:05
The latest update is out from Leap Therapeutics ( ($LPTX) ). On March 12, 2025,...
09-12 05:02
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Leap Therapeutics shares are trading lower after the company reported a Q2 EPS ...
08-14 20:35
7月2日,沪深两市双双收跌,成交量有所萎缩。板块方面钢铁、光伏设备涨幅居前,元件、通信设备板块跌幅居前。人气股方面亚星锚链收于涨停,安妮股份、长城军工跌幅居前。
07-02 16:03
Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEGF-naïve and liver metastasis subgroups
06-23 19:07
Leap Therapeutics ( ($LPTX) ) has released its Q1 earnings. Here is a breakdown...
05-28 11:52